FIRST LINE BE-WEEKLY REGIMEN WITH DOCETAXEL AND GEMCITABINE IN HER-2 NEGATIVE AND ANTRACYCLINE-PRETREATED METASTATIC BREAST CANCER (MBC) PATIENTS: PRELIMINARY RESULTS OF A MULTICENTER PHASE II TRIAL

被引：0

作者：

Murialdo, R. ^{[1
]}

Bertolotti, F. ^{[2
]}

Tixi, L. ^{[1
]}

Boy, D. ^{[1
]}

Martini, M. C. ^{[2
]}

Pastorino, G. ^{[2
]}

Sogno, G. ^{[2
]}

Vaira, F. ^{[3
]}

Bergaglio, M. ^{[4
]}

Mencoboni, M. ^{[4
]}

Simoni, C.

Parodi, M. ^{[5
]}

Canobbio, L. ^{[5
]}

Folco, U. ^{[6
]}

Ballestrero, A. ^{[1
]}

Brema, F. ^{[2
]}

机构：

[1] Osped San Martino Genova, Dipartimento Med Interna Ad Indirizzo Oncol, Genoa, Italy

[2] Osped San Paolo, Dipartimento Oncol, Savona, Italy

[3] Osped S Andrea, Dipartimento Oncol, La Spezia, Italy

[4] Osped Villa Scassi, UO Oncol, Genoa, Italy

[5] Osp P Micone, Semplice Oncol Med, Genoa, Italy

[6] Osped Santa Corona, SC Oncol Med, Pietra Ligure, SV, Italy

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：1